Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 30, 2026 08:09 UTC |
Nimrodi NirDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001178913-26-004662 · ownership.xml · derivative · entry 1 Nimrodi Nir · CIK 0001602806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-09-04 F1 · derivative.exercise_price: The exercise price of the stock options to purchase Ordinary Shares of the Issuer (the "Options") is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date. F2 · kind: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 10,000 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan. F3 · derivative.exercise_date: The Options vest and become exercisable on a quarterly basis (25% per quarter) commencing on the grant date of September 4, 2026, such that they will be fully vested by September 4, 2027, the one-year anniversary of the grant date. Read SEC document |
| September 04, 2026 Filed Sep 30, 2026 08:05 UTC |
Falk Dan MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001178913-26-004658 · ownership.xml · derivative · entry 1 Falk Dan Michael · CIK 0001966097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 2,500 shares Expires 2036-09-04 F1 · derivative.exercise_price: The exercise price of the stock options to purchase Ordinary Shares of the Issuer (the "Options") is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date. F2 · kind: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options under the Issuer's 2021 Share Incentive Plan. F3 · derivative.exercise_date: The Options vest and become exercisable on a quarterly basis (25% per quarter) commencing on the grant date of September 4, 2026, such that they will be fully vested by September 4, 2027, the one-year anniversary of the grant date. Read SEC document |
| September 04, 2026 Filed Sep 30, 2026 08:07 UTC |
Percy Adrian JohnDirector
|
GrantStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001178913-26-004660 · ownership.xml · derivative · entry 1 Percy Adrian John · CIK 0001980816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 2,500 shares Expires 2036-09-04 F1 · derivative.exercise_price: The exercise price of the stock options to purchase Ordinary Shares of the Issuer (the "Options") is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date. F2 · kind: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options under the Issuer's 2021 Share Incentive Plan. F3 · derivative.exercise_date: The Options vest and become exercisable on a quarterly basis (25% per quarter) commencing on the grant date of September 4, 2026, such that they will be fully vested by September 4, 2027, the one-year anniversary of the grant date. Read SEC document |
| September 04, 2026 Filed Sep 30, 2026 08:13 UTC |
RECANATI LEONDirector
|
GrantStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001178913-26-004664 · ownership.xml · derivative · entry 2 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 2,500 shares Expires 2036-09-04 F2 · derivative.exercise_price: The exercise price of the options to purchase Ordinary Shares of the Issuer (the "Options") reported in this row is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date. F3 · kind: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan, F4 · derivative.exercise_date: The Options vest and become exercisable on a quarterly basis (25% per quarter), commencing on September 4, 2026, such that the Options will be fully vested on September 4, 2027, the one-year anniversary of the grant date. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 11:00 UTC |
RECANATI LEONDirector
|
PurchaseOrdinary Shares | 460,000 | $0.64 | $292,100.00 |
DisclosureSEC source: 0001178913-26-004095 · ownership.xml · nonDerivative · entry 1 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,343,886 Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:07 UTC |
RECANATI LEONDirector
|
PurchaseOrdinary Shares | 800,000 | $0.50 | $400,000.00 |
DisclosureSEC source: 0001178913-26-003859 · ownership.xml · nonDerivative · entry 1 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 883,886 F1 · price: The price reported in column 4 of this row is a weighted average price. These shares were purchased in multiple transactions on August 4, 2026 within a range of prices per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 04, 2026 Filed Aug 26, 2026 20:00 UTC |
Tarcic GabiChief Development Officer
|
PurchaseOrdinary Shares | 1,129 | $0.60 | $677.40 |
DisclosureSEC source: 0001178913-26-004259 · ownership.xml · nonDerivative · entry 1 Tarcic Gabi · CIK 0002085020 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,129 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.